Hyloris Pharmaceuticals SA (LON:0AB6)
London
· Delayed Price · Currency is GBP · Price in EUR 6.60
0.00 (0.00%)
At close: Apr 22, 2025
Hyloris Pharmaceuticals Revenue
In the year 2024, Hyloris Pharmaceuticals had annual revenue of 10.04M EUR with 138.30% growth. Hyloris Pharmaceuticals had revenue of 5.40M in the half year ending December 31, 2024, with 298.97% growth.
Revenue
10.04M EUR
Revenue Growth
+138.30%
P/S Ratio
18.27
Revenue / Employee
204.94K EUR
Employees
49
Market Cap
151.71M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| HSBC Holdings | 48.93B |
| Shell | 227.10B |
| Unilever | 50.25B |
| Rio Tinto Group | 42.86B |
| RELX PLC | 9.43B |
| British American Tobacco p.l.c. | 25.87B |
| Rolls-Royce Holdings | 18.91B |